.webp)
Capture the Best of Both
Worlds With Accurate and
Cost-Effective In-House Fusion
MRI-US fusion is clinically proven to detect higher rates of prostate cancer compared to traditional ultrasound-guided biopsies. While in-house fusion is well-understood to provide unmatched access and clinical benefits to patients, many practices simply can’t afford the costs and workflow disruptions that come with a new fusion system — that’s where Navigo comes in. Navigo was specifically designed to remove barriers to in-house fusion by offering a simple solution that benefits both practices and patients. Schedule a call to find out how Navigo can:
Enhance your biopsy precision by compensating for patient movement in real time
Safeguard your bottom line with low upfront costs and new practice revenue streams
Streamline your fusion workflow by eliminating manual repositioning, re-registration and biopsy marking
Schedule a Discovery Call
Rapidly Navigate and Accurately Identify Regions of Interest Without Interruption or Delays
Accurate
MRI-guided biopsies are 46% more sensitive than standard "blind" biopsies.
Automatic
Automatic biopsy marking eliminates the need for hand or pedals and follows your ultrasound workflow — no manual steps, stopping or waiting.
Affordable
Navigo is cost-effective for any practice, with no extra costs and easy integration with your ultrasound system, biopsy gun, and needles.
Accurate, Simple Steps to Biopsy Optimization
STEP 1 | PREPARATION
Plan for fusion by importing historical biopsy data and accurately identifying targets with Navigo Fusion Studio. Navigo’s 4D navigation is compatible with most commercially available ultrasounds, offering automatic prostate contouring and fusion assistance.
STEP 2 | BIOPSY PROGRESSION
Navigo automatically adjusts to ultrasound settings and patient movement in real time, eliminating the need to restart the procedure. Perform transperineal or transrectal biopsies with your transducer, avoiding any buttons or pedals with automatic biopsy location marking as you proceed.
STEP 3 | REVIEW AND REPORTING
Generate comprehensive procedure reports and display 3D pathology results, allowing the physician to rapidly review the full biopsy and evaluate regions of interest.
Experience The Freedom of Precision
UROLOGY WHITE PAPER
Gaps in Current Prostate Biopsy Processes
Crucial steps to increasing the prostate cancer diagnosis rate from biopsy targeting to slide.
Download the white paper to discover strategies for maximizing precision and overcoming the two primary challenges that urologists face when diagnosing prostate cancer.
